References
- HoffmannHHSchneiderWMRiceCMInterferons and viruses: an evolutionary arms race of molecular interactionsTrends Immunol201536312413825704559
- ZitvogelLGalluzziLKeppOSmythMJKroemerGType I interferons in anticancer immunityNat Rev Immunol201515740541426027717
- StiffACarson IiiWInvestigations of interferon-lambda for the treatment of cancerJ Innate Immun2015724325025661266
- de WeerdNANguyenTThe interferons and their receptors – distribution and regulationImmunol Cell Biol201290548349122410872
- SchneiderWMChevillotteMDRiceCMInterferon-stimulated genes: a complex web of host defensesAnnu Rev Immunol20143251354524555472
- GibbertKSchlaakJFYangDDittmerUIFN-alpha subtypes: distinct biological activities in anti-viral therapyBr J Pharmacol201316851048105823072338
- SchoenbornJRWilsonCBRegulation of interferon-gamma during innate and adaptive immune responsesAdv Immunol2007964110117981204
- KotenkoSVGallagherGBaurinVVIFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complexNat Immunol200341697712483210
- SheppardPKindsvogelWXuWIL-28, IL-29 and their class II cytokine receptor IL-28RNat Immunol200341636812469119
- Prokunina-OlssonLMuchmoreBTangWA variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNat Genet201345216417123291588
- OuyangWRutzSCrellinNKValdezPAHymowitzSGRegulation and functions of the IL-10 family of cytokines in inflammation and diseaseAnnu Rev Immunol2011297110921166540
- ZdanovAStructural analysis of cytokines comprising the IL-10 familyCytokine Growth Factor Rev201021532533020846897
- MiknisZJMagrachevaELiWZdanovAKotenkoSVWlodawerACrystal structure of human interferon-lambda1 in complex with its high-affinity receptor interferon-lambdaR1J Mol Biol2010404465066420934432
- GadHHDellgrenCHammingOJVendsSPaludanSRHartmannRInterferon-lambda is functionally an interferon but structurally related to the interleukin-10 familyJ Biol Chem200928431208692087519457860
- BlouinCMLamazeCInterferon gamma receptor: the beginning of the journeyFront Immunol2013426724027571
- LinFCYoungHAInterferons: success in anti-viral immunotherapyCytokine Growth Factor Rev201425436937625156421
- GeorgePMBadigerRAlazawiWFosterGRMitchellJAPharmacology and therapeutic potential of interferonsPharmacol Ther20121351445322484806
- YinZDaiJDengJType III IFNs are produced by and stimulate human plasmacytoid dendritic cellsJ Immunol201218962735274522891284
- WolkKWitteKWitteEMaturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesJ Leukoc Biol20088351181119318281438
- KotenkoSVIFN-lambdasCurr Opin Immunol201123558359021840693
- HermantPMichielsTInterferon-lambda in the context of viral infections: production, response and therapeutic implicationsJ Innate Immun20146556357424751921
- EgliASanterDMO’SheaDTyrrellDLHoughtonMThe impact of the interferon-lambda family on the innate and adaptive immune response to viral infectionsEmerg Microbes Infect201437e5126038748
- WitteKWitteESabatRWolkKIL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like propertiesCytokine Growth Factor Rev201021423725120655797
- ZhouZHammingOJAnkNPaludanSRNielsenALHartmannRType III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinasesJ Virol200781147749775817507495
- DoyleSESchreckhiseHKhuu-DuongKInterleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytesHepatology200644489690617006906
- PottJMahlakoivTMordsteinMIFN-lambda determines the intestinal epithelial antiviral host defenseProc Natl Acad Sci U S A2011108197944794921518880
- MordsteinMNeugebauerEDittVLambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infectionsJ Virol201084115670567720335250
- SommereynsCPaulSStaeheliPMichielsTIFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivoPLoS Pathog200843e100001718369468
- MuirAJShiffmanMLZamanAPhase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infectionHepatology201052382283220564352
- MuirAJAroraSEversonGA randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infectionJ Hepatol20146161238124625064437
- RamosELPreclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis CJ Interferon Cytokine Res201030859159520645873
- MahlakoivTHernandezPGronkeKDiefenbachAStaeheliPLeukocyte-derived IFN-alpha/beta and epithelial IFN-lambda constitute a compartmentalized mucosal defense system that restricts enteric virus infectionsPLoS Pathog2015114e100478225849543
- HernandezPPMahlakoivTYangIInterferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infectionNat Immunol201516769870726006013
- GallagherGMegjugoracNJYuRYThe lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 responseJ Interferon Cytokine Res201030860361520712455
- NiceTJBaldridgeMTMcCuneBTInterferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunityScience2015347621926927325431489
- ContoliMMessageSDLaza-StancaVRole of deficient type III interferon-lambda production in asthma exacerbationsNat Med20061291023102616906156
- KochSFinottoSRole of interferon-lambda in allergic asthmaJ Innate Immun2015722423025592858
- AngelJFrancoMAGreenbergHBBassDLack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in miceJ Interferon Cytokine Res199919665565910433367
- DellgrenCGadHHHammingOJMelchjorsenJHartmannRHuman interferon-lambda3 is a potent member of the type III interferon familyGenes Immun200910212513118987645
- WeberHValenzuelaDLujberGGublerMWeissmannCSingle amino acid changes that render human IFN-alpha 2 biologically active on mouse cellsEMBO J1987635915983034596
- SpanglerJBMoragaIMendozaJLGarciaKCInsights into cytokine–receptor interactions from cytokine engineeringAnnu Rev Immunol201533113916725493332
- GasteigerEHooglandCGattikerAProtein Identification and Analysis Tools on the ExPASy ServerWalkerJMThe Proteomics Protocols Handbook, Humana Press 2005Totowa, New JerseyHumana Press2005571607
- PaulsonMSGeneration and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc)EnnaSJWilliamsMCurrent Protocols in PharmacologyNew YorkJohn Wiley & Sons, Inc201013B.14.1113B.14.19
- AmanzadaAKoppWSpenglerURamadoriGMihmSInterferon-lambda4 (IFNL4) transcript expression in human liver tissue samplesPLoS One2013812e8402624376784
- LarocqueLBliuAXuRBioactivity determination of native and variant forms of therapeutic interferonsJ Biomed Biotechnol2011201117461521403871
- ChanHLAhnSHChangTTO115 PEGInterferon lambda for the treatment of chronic hepatitis B (CHB): a phase 2B comparison with PEGinterferon alfa in patients with HBeAg-positive diseaseJ Hepatol2014601S48
- WongSSYuenKYAntiviral therapy for respiratory tract infectionsRespirology200813795097118922142
- JewellNAClineTMertzSELambda interferon is the predominant interferon induced by influenza A virus infection in vivoJ Virol20108421115151152220739515
- MatzingerSRCarrollTDFrittsLMcChesneyMBMillerCJExogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaquesPLoS One2011612e2925522220209
- LevinDSchneiderWMHoffmannHHMultifaceted activities of type I interferon are revealed by a receptor antagonistSci Signal20147327ra5024866020
- BlattLMDavisJMKleinSBTaylorMWThe biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferonJ Interferon Cytokine Res19961674894998836913
- WitthoftTReview of consensus interferon in the treatment of chronic hepatitis CBiologics20082463564319707444
- ChangCCChenTTCoxBWEvolution of a cytokine using DNA family shufflingNat Biotechnol199917879379710429246
- Brideau-AndersenADHuangXSunSCDirected evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseasesProc Natl Acad Sci U S A2007104208269827417494769
- Kimchi-SarfatyCSchillerTHamasaki-KatagiriNKhanMAYanoverCSaunaZEBuilding better drugs: developing and regulating engineered therapeutic proteinsTrends Pharmacol Sci2013341053454824060103